Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029)

Meningococcal group A, C, W-135 and Y conjugate vaccine (Men ACWY) 2026-2027 (2028, 2029) The Ministry of Social Affairs and Health (later referred to as ”STM”) and the Finnish Institute for Health and Welfare (later referred to as "THL" or “Customer” ) request your tender for Meningococcal group A, C, W-135 and Y conjugate vaccine, required for the vaccinations in the Finnish Defence Forces and the Finnish Border Guard and for the risk group vaccinations in the National Vaccination Programme in Finland. The contract period is two years 2026 - 2027. The procurement contains two one-year contract period renewals (1 + 1) to extend the contract for the periods 2028 and 2029. Estimated quantity for the contract period including contract period renewals is 112,000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20%. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The most economically advantageous Tender shall be a Tender with lowest price. Please note that all times given in the Call for Tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Delivery schedule Annex 4 Subcontractors Annex 5 Description of the Handi Service,